BRIEF-Medical Device Company NanoVibronix Signs Agreement For R&D Of Next Generation PainShield, UroShield

Reuters03-28

March 28 (Reuters) - Nanovibronix Inc :

* NANOVIBRONIX SIGNS AGREEMENT FOR RESEARCH AND DEVELOPMENT OF NEXT GENERATION PAINSHIELD AND UROSHIELD

* NANOVIBRONIX INC - EFFORTS FOCUSED ON ADDING THERAPEUTIC FUNCTIONALITY AND REDUCING COSTS

* NANOVIBRONIX INC - UNDER TERMS OF AGREEMENT, VERANEX WILL PROVIDE CERTAIN RESEARCH AND DEVELOPMENT SERVICES AS RELATED TO PAINSHIELD AND UROSHIELD

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2422115755?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-28 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2422115755","market":"us","top_or_hot":-1,"title":"BRIEF-Medical Device Company NanoVibronix Signs Agreement For R&D Of Next Generation PainShield, UroShield","media":"Reuters","content":"<html><body><p>March 28 (Reuters) - Nanovibronix Inc   :</p><p>   * NANOVIBRONIX SIGNS AGREEMENT FOR RESEARCH AND DEVELOPMENT OF NEXT GENERATION PAINSHIELD AND UROSHIELD</p><p>   * NANOVIBRONIX INC - EFFORTS FOCUSED ON ADDING THERAPEUTIC FUNCTIONALITY AND REDUCING COSTS</p><p>   * NANOVIBRONIX INC - UNDER TERMS OF AGREEMENT, VERANEX WILL PROVIDE CERTAIN RESEARCH AND DEVELOPMENT SERVICES AS RELATED TO PAINSHIELD AND UROSHIELD</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Medical Device Company NanoVibronix Signs Agreement For R&D Of Next Generation PainShield, UroShield</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Medical Device Company NanoVibronix Signs Agreement For R&D Of Next Generation PainShield, UroShield\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-28 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 28 (Reuters) - Nanovibronix Inc   :   * NANOVIBRONIX SIGNS AGREEMENT FOR RESEARCH AND DEVELOPMENT OF NEXT GENERATION PAINSHIELD AND UROSHIELD   * NANOVIBRONIX INC - EFFORTS FOCUSED ON ADDING ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2422115755","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422115755","pubTimestamp":1711638258,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 28  - Nanovibronix Inc   :   * NANOVIBRONIX SIGNS AGREEMENT FOR RESEARCH AND DEVELOPMENT OF NEXT GENERATION PAINSHIELD AND UROSHIELD   * NANOVIBRONIX INC - EFFORTS FOCUSED ON ADDING THERAPEUTIC FUNCTIONALITY AND REDUCING COSTS   * NANOVIBRONIX INC - UNDER TERMS OF AGREEMENT, VERANEX WILL PROVIDE CERTAIN RESEARCH AND DEVELOPMENT SERVICES AS RELATED TO PAINSHIELD AND UROSHIELDSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","NAOV":"NanoVibronix Inc"},"translate_title":"医疗器械公司NanoVibronix签署协议研发下一代PainShield，UroShield","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAOV":0.9},"content_text":"March 28 (Reuters) - Nanovibronix Inc   :   * NANOVIBRONIX SIGNS AGREEMENT FOR RESEARCH AND DEVELOPMENT OF NEXT GENERATION PAINSHIELD AND UROSHIELD   * NANOVIBRONIX INC - EFFORTS FOCUSED ON ADDING THERAPEUTIC FUNCTIONALITY AND REDUCING COSTS   * NANOVIBRONIX INC - UNDER TERMS OF AGREEMENT, VERANEX WILL PROVIDE CERTAIN RESEARCH AND DEVELOPMENT SERVICES AS RELATED TO PAINSHIELD AND UROSHIELDSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422115755"}